SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob Rudd who wrote (20903)3/17/2005 4:10:36 PM
From: Madharry   of 78696
 
Riverdance through the minefield. I like that but at some point there has to be some kind of measured balance of the effectiveness of the drug vis-a vis potential lethal side effects and can those risks be managed. The alternative will be people with MS for example flocking to foreign specialty clinics for treatments which will much less monitored than if the drug were carefully administered in the U.S.A. I am beginning to wonder if aspirin could garner fda approval in todays environment.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News